Research & Development

we maintain and promote a strong commitment to our own research and development, materialized in the

 we maintain and promote a strong commitment to our own research and development, materialized in the constant search for original molecules, drug associations and new pharmaceutical forms, assessment of the pharmacological profile and its pharmaceutical-analytical development .

 we maintain and promote a strong commitment to our own research and development, materialized in the constant search for original molecules, drug associations and new pharmaceutical forms, assessment of the pharmacological profile and its pharmaceutical-analytical development .


image6

Generate excitement

 

  1. All of these achievements have been supported by the scientific rigorousness of our research teams – highly qualified professionals with a multidisciplinary background – mainly focused on the search of new therapeutic responses aimed at enhancing the quality of life, health and welfare of people.
  2. technologies, diverse therapeutic expertise and access to commercial insights that can facilitate shorter and more efficient trials designed to improve the likelihood of regulatory and commercial success.

image7

Clinical Development

 we can adopt new processes and technologies, diverse therapeutic expertise and access to commercial insights that can facilitate shorter and more efficient trials designed to improve the likelihood of regulatory and commercial success. 

Dynamic Research

image8

 

  1. Phase I research involves constantly moving elements, including toxicology results, regulatory requirements, program optimization, study design strategy and drug readiness. Initial human data are a critical development milestone. Our multidisciplinary Phase I PRO team of top experts can work as an extension of your team, to provide tactical options tailored to your asset’s early development, guiding you to proof-of-concept swiftly, with a meaningful exit

image9

Clinical trials

 

  • To register clinical trials on freely accessible internet registries, 
  • To disclose clinical trial information (including results) on freely accessible internet registries,
  • Meet the EFPIA Principles for Responsible Clinical Trial Data Sharing.
    • Enhance data sharing with researchers.
    • Enhance public access to clinical trial information.
    • Share results with patients who participate in clinical trials.
    • Certify procedures for sharing clinical trial information.
    • Commitment to publish clinical trial results.
  • Protect subject privacy when disclosing or sharing clinical trial information.

image10

 

Life is EVERYONE.

Our mission is to deliver solutions and bring hope to as many people as possible. Biosimilar medicines enable us to do so, by ensuring access to treatments and contributing to the sustainability of healthcare systems worldwide.

Life is TRUST.

Trust built on the values and the experience of a dynamic, multi-disciplinary and highly qualified team.

The application of a unified work methodology, with a focus on quality in everything we do.

Life is GROWTH

Growth driven by passion and commitment, enabling us to enter any market and adapt to challenges with dedication and talent.

Welcome

 Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health